Key terms

About LNTH

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LNTH news

Mar 06 8:25pm ET Buy Rating on Lantheus Holdings Amid Overlooked Pylarify Growth and Market Expansion Opportunities Mar 05 9:21pm ET Lantheus director sells $6.13M in common stock Mar 05 8:15am ET Perspective Therapeutics acquires CGMP-compliant manufacturing facility Mar 04 8:37am ET Lantheus announces FDA approval of DEFINITY for pediatric patients Mar 01 4:55am ET Lantheus management to meet with B. Riley Feb 28 8:32am ET Lantheus appoints Amanda Morgan as CCO Feb 26 9:51am ET Lantheus price target raised to $82 from $80 at Truist Feb 26 7:16am ET Truist Financial Sticks to Its Buy Rating for Lantheus (LNTH) Feb 26 1:15am ET Lantheus Holdings: A Strong Buy on Robust Pylarify Performance and Favorable Market Dynamics Feb 25 11:25pm ET Lantheus Holdings: Strong Buy on Robust Q4 Earnings and Promising Growth Prospects Feb 23 11:15am ET Lantheus management to meet with B. Riley Feb 23 9:00am ET Lantheus price target raised to $128 from $114 at JonesResearch Feb 23 8:40am ET Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX) Feb 23 12:40am ET Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Evolent Health (EVH) Feb 22 9:45pm ET Buy Rating Affirmed for Lantheus Holdings on Strong Performance and Positive Market Outlook Feb 22 12:50pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Moderna (MRNA) and Lantheus (LNTH) Feb 22 7:05am ET Lantheus sees Q1 adjusted EPS $1.50-$1.54, consensus $1.51 Feb 22 7:05am ET Lantheus sees FY24 adjusted EPS $6.50-$6.70, consensus $6.25 Feb 22 7:04am ET Lantheus reports Q4 adjusted EPS $1.75, consensus $1.45 Feb 15 1:20am ET Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH), Incyte (INCY) and Fusion Pharmaceuticals (FUSN) Jan 28 5:24am ET TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Considering at Current Low Levels Jan 26 12:46am ET Stable Transition and Strategic Continuity Justify Buy Rating for Lantheus Holdings Jan 26 12:36am ET Buy Rating Affirmed for Lantheus with Leadership Transition and Strategic Oncology Focus Jan 24 3:08am ET Lantheus Announces CEO Retirement and Successor Appointment Jan 23 10:56am ET Buy Rating Affirmed for Lantheus: Strategic Leadership and Strong Financials Signal Growth Jan 23 7:48am ET Lantheus reaffirms 2023 revenue view $1.295B-$1.297B, consensus $1.28B Jan 23 7:47am ET Lantheus CEO Mary Anne Heino to retire, Brian Markison to succeed Jan 15 2:20pm ET Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Roche Holding AG (OtherRHHVF) Jan 11 3:35pm ET Lantheus: A Buy Rating Based on Strategic Growth and Diversified Radiopharmaceutical Pipeline Jan 11 8:05am ET Lantheus announces acceptance of its first-to-file ANDA for generic LUTATHERA Jan 11 1:41am ET Leerink Partners Sticks to Its Buy Rating for Lantheus (LNTH)

No recent news articles are available for LNTH

No recent press releases are available for LNTH

LNTH Financials

1-year income & revenue

Key terms

LNTH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LNTH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms